Form 4: InnovAge CEO Patrick Blair Reports Stock Tax Withholding

InnovAge Holding Corp. CEO Patrick Blair reported the withholding of 21,969 shares to satisfy tax obligations related to RSU vesting.

Summary

• CEO Patrick Blair disposed of a total of 21,969 shares of common stock across two transactions on June 5 and June 6, 2026.
• The transactions were executed at a price of $7.30 per share.
• The shares were withheld by the company to satisfy tax withholding obligations associated with the vesting and settlement of restricted stock units (RSUs).
• Following these transactions, the CEO maintains a beneficial ownership of 687,103 shares of InnovAge common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction is a mandatory tax compliance action rather than a discretionary sale of stock.

Positives

• The transaction reflects the vesting of equity compensation, which is a standard component of executive incentive structures.

Negatives

• The transaction results in a reduction of the CEO's direct share ownership, though it is purely for tax compliance purposes.

Risks

• General market risks associated with the healthcare services sector.
• Regulatory and compliance risks inherent to the PACE (Program of All-Inclusive Care for the Elderly) model operated by the company.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that this filing is a routine administrative disclosure common in the healthcare sector, where executive compensation packages are heavily weighted toward equity to align management interests with long-term shareholder value.

Comparison to Industry Standards

• The use of 'sell-to-cover' or share withholding for tax obligations is a standard industry practice for publicly traded companies to manage executive tax liabilities upon RSU vesting.

Stakeholder Impact

• Minimal impact on shareholders as the transaction is a routine tax-related adjustment.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

InnovAge, INNV, Insider Trading, Form 4, Executive Compensation, Healthcare Services